AEON Biopharma
AEON
AEON
19 hedge funds and large institutions have $56.8M invested in AEON Biopharma in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
6
Increased
4
Reduced
3
Closed
2
Calls
$576K
Puts
–
Net Calls
+$576K
Net Calls Change
+$576K
Top Buyers
1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
$26.2M |
2 |
Northern Trust
Chicago,
Illinois
|
$359K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.51M |
4 |
State Street
Boston,
Massachusetts
|
$72.4K |
5 |
![]()
JPMorgan Chase & Co
New York
|
$49.6K |